| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/24/2005 | CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 08/24/2005 | CN1658868A Bazedoxifene treatment regimens |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658854A Immunity-related protein kinase inhibitors |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658842A Novel polymorphs and pseudopolymorphs of risedronate sodium |
| 08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 08/24/2005 | CN1657540A Polyethylene glycol derivative of human parathyrin (1-34), medicinal composition containing same and use |
| 08/24/2005 | CN1657539A Human connective tissue growth factor mutant protein and its application |
| 08/24/2005 | CN1657095A Chinese herbal medicinal powder for treating atrophic arthritis |
| 08/24/2005 | CN1657088A Medicinal composition for treating rheumatism atrophic arthritis |
| 08/24/2005 | CN1657087A Medicinal composition for treating rheumatism atrophic arthritis |
| 08/24/2005 | CN1657086A Medicinal composition for treating rheumatism atrophic arthritis |
| 08/24/2005 | CN1657076A Medicinal incense possessing health-care function |
| 08/24/2005 | CN1657039A Dry adhesive plaster of powdered ointment |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1215876C Antigout medicinal composition and its preparing method |
| 08/24/2005 | CN1215875C Peroral Chinese medicine powder for treating bone fracture and its preparing process |
| 08/24/2005 | CN1215863C Capsule for treating fracture and its production process |
| 08/24/2005 | CN1215838C Declofenac sodium pastes and preparation thereof |
| 08/23/2005 | US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933295 Substituted isoindoles and the use thereof |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/18/2005 | WO2005075414A1 Peptidyl arginine deiminase type iv inhibitor |
| 08/18/2005 | WO2005074919A1 Diurea derivatives |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | WO2005074905A1 Therapeutic/preventive agent for osteoporosis containing as component isotaxiresinol derived from taxus yunnanensis |
| 08/18/2005 | WO2005013909A3 Novel cathepsin k inhibitors |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 08/18/2005 | US20050182093 Novel compounds |
| 08/18/2005 | US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 08/18/2005 | US20050182057 Aryl N-cyanoguanidines and methods related thereto |
| 08/18/2005 | US20050182045 Fused ring 4-oxopyrimidine derivative |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |
| 08/18/2005 | US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 08/18/2005 | US20050182030 Antitumor, anticancer agents; osteoporosis; bone disorders; Paget's disorders; solution is provided in a sealed non-reactive plastic container of polypropylene, ABS, polyethylene, PVC, polycycloolefin; injectable, sterile, ready to use, pyrogen-free solution |
| 08/18/2005 | US20050182019 Phosphonate compounds |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 08/18/2005 | US20050180973 TREM-1 splice variant for use in modifying immune responses |
| 08/18/2005 | US20050180959 Kinases involved in the regulation of energy homeostasis |
| 08/18/2005 | DE102004004974A1 Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen Thieno-imino acid derivatives as inhibitors of matrix metalloproteinases |
| 08/18/2005 | DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease |
| 08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
| 08/18/2005 | CA2555296A1 Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors |
| 08/18/2005 | CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 08/18/2005 | CA2555199A1 Peptidylarginine deiminase 4 inhibitor |
| 08/18/2005 | CA2552942A1 New compounds, methods for their preparation and use thereof |
| 08/18/2005 | CA2551566A1 Diurea derivatives |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1563841A1 Remedies |
| 08/17/2005 | EP1562949A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1351680B8 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity |
| 08/17/2005 | EP1315496B1 The treatment of inflammatory disorders |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1181274A4 Iminocyclitol inhibitors of hexoaminidase and glycosidase |
| 08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
| 08/17/2005 | EP1087943B1 Therapeutic biaryl derivatives |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 08/17/2005 | CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 08/17/2005 | CN1656098A Fused bicyclic pyrimidine derivatives |
| 08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 08/17/2005 | CN1656089A Phenyl-thiophene type vitamin D receptor modulators |
| 08/17/2005 | CN1656084A Hydroxymorpholinone derivative and medicinal use thereof |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1655848A Use of new etonogestrel esters |
| 08/17/2005 | CN1655845A Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 08/17/2005 | CN1655823A Topically applicable pharmaceutical preparation |
| 08/17/2005 | CN1655815A Process for the preparation and activation of substances and a means of producing same |
| 08/17/2005 | CN1655810A Composition for treating or preventing hyperuricemia |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655802A Bioadhesive directed somatic cell therapy |
| 08/17/2005 | CN1655798A Mixed-cell gene therapy |
| 08/17/2005 | CN1655797A Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone |
| 08/17/2005 | CN1655796A Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a SERM |